The promise of retinoids to fight against cancer
The DOI matches its Crossref record; 150 of the 150 references it cites were found in a registry or an index.
Abstract
Retinoids have a reputation for being both detrimental and beneficial: they are teratogens, but they also have tumour-suppressive capacity. Cell biology and genetics have significantly improved our understanding of the mechanisms that underlie the anti-proliferative action of retinoids. Recent elucidation of the pathways that are activated by retinoids will help us to exploit the beneficial aspects of this powerful class of compounds for cancer therapy and prevention.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Apart from the well-known indications in hypovitaminosis and skin diseases, retinoids have been successfully used in treating cancer”
From Vitamin A Update: Forms, Sources, Kinetics, Detection, Function, Deficiency, Therapeutic Use and Toxicity (2021) · cites this paper as [187]
In the citing paper
“The FDA has approved ATRA to treat cystic acne and several cancers, such as some lymphoma and leukemia”
From Vitamin A Update: Forms, Sources, Kinetics, Detection, Function, Deficiency, Therapeutic Use and Toxicity (2021) · cites this paper as [187]
Citations
Cites
The coregulator exchange in transcriptional functions of nuclear receptors
Glass, C. K., & Rosenfeld, M. G. (2000) · Genes & Development · doi:10.1101/gad.14.2.121 · Cited by 2,233 · cited 8×
“a | The t(15;17) chromosomal translocation generates the PML–RARα fusion protein that, in contrast to RARα, can efficiently dimerize or oligomerize, thereby recruiting multiple HDAC complexes and leading to ‘super-repression’ of target genes.”
BackgroundInfluentialKamei, Y., Xu, L., Heinzel, T., Torchia, J., Kurokawa, R., Gloss, B., Lin, S.-C., Heyman, R. A., Rose, D. W., Glass, C. K., et al. (1996) · Cell · doi:10.1016/s0092-8674(00)81118-6 · Cited by 2,150
Matthay, K. K., Villablanca, J. G., Seeger, R. C., Stram, D. O., Harris, R. E., Ramsay, N. K., Swift, P., Shimada, H., Black, C. T., Brodeur, G. M., et al. (1999) · New England Journal of Medicine · doi:10.1056/nejm199910143411601 · Cited by 1,898
ABC of breast diseases. Breast cancer-epidemiology, risk factors, and genetics
McPherson, K. (2000) · BMJ · doi:10.1136/bmj.321.7261.624 · Cited by 1,570
Hong, W. K., Lippman, S. M., Itri, L. M., Karp, D. D., Lee, J. S., Byers, R. M., Schantz, S. P., Kramer, A. M., Lotan, R., Peters, L. J., et al. (1990) · New England Journal of Medicine · doi:10.1056/nejm199009203231205 · Cited by 1,365
The retinoids—Biology, chemistry and medicine
(1996) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/s0960-0760(97)80793-5 · Cited by 1,178
Histone Deacetylase Inhibitors: Inducers of Differentiation or Apoptosis of Transformed Cells
Marks, P. A., Richon, V. M., & Rifkind, R. A. (2000) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/92.15.1210 · Cited by 1,157
Embryonic retinoic acid synthesis is essential for early mouse post-implantation development
Niederreither, K., Subbarayan, V., Dollé, P., & Chambon, P. (1999) · Nature Genetics · doi:10.1038/7788 · Cited by 1,077
Role of the histone deacetylase complex in acute promyelocytic leukaemia
Lin, R. J., Nagy, L., Inoue, S., Shao, W., Miller, W. H., & Evans, R. M. (1998) · Nature · doi:10.1038/35895 · Cited by 1,062 · cited 1×
“However, high concentrations of HDAC inhibitors (HDACi) can convert even PLZF–RARα into an activator of the RA signalling pathwa”
BackgroundGrignani, F., De Matteis, S., Nervi, C., Tomassoni, L., Gelmetti, V., Cioce, M., Fanelli, M., Ruthardt, M., Ferrara, F. F., Zamir, I., et al. (1998) · Nature · doi:10.1038/35901 · Cited by 1,004 · cited 1×
“However, high concentrations of HDAC inhibitors (HDACi) can convert even PLZF–RARα into an activator of the RA signalling pathwa”
Background
Research works printed but not linked: 1
- Moon, R. C., Mehta, R. G. & Rao, K. J. V. N. in The Retinoids (eds Sporn, M. B., Roberts, A. B. & Goodman, D. S.) 573–595 (Raven, New York, 1994).
Cited by
Items 301–400 of 784
Varshosaz, J., Hassanzadeh, F., Sadeghi, H., Ghelichkhan, Z. A., & Rostami, M. R. (2013) · Journal of Nanomaterials · doi:10.1155/2013/254127 · Cited by 36
“Retinoic acid (R) is a derivative of vitamin A with an important role in regulation of cell proliferation and differentiation [25], and its inhibitory effect on cancer cell growth is well established [26–30].”
BackgroundGRIM-19 function in cancer development
Moreira, S., Correia, M., Soares, P., & Máximo, V. (2011) · Mitochondrion · doi:10.1016/j.mito.2011.05.011 · Cited by 34
Retinoids for preventing the progression of cervical intra-epithelial neoplasia
Helm, C. W., Lorenz, D. J., Meyer, N. J., Rising, W., & Wulff, J. L. (2013) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd003296.pub3 · Cited by 33
Singh, B., Murphy, R. F., Ding, X., Roginsky, A. B., Bell, R. H., & Adrian, T. E. (2007) · Molecular Cancer · doi:10.1186/1476-4598-6-82 · Cited by 33
“In some cancer cell types, retinoic acid-mediated growth inhibition is associated with reduced expression of transcription factors such as c-myc, c-myb, p53, pRB and also decreased expression of epidermal growth factor receptor [4].”
BackgroundZhang, X., Yang, X., Sun, C., Hu, B., Sun, Y., Huang, X., Wang, Z., He, Y., Zeng, H., Qiu, S., et al. (2015) · Cancer Letters · doi:10.1016/j.canlet.2015.06.014 · Cited by 33
“The promyelocytic leukemia-retinoic acid receptor α (PMLRARα) fusion protein plays an important role in the pathogenesis of APL, and its presence disrupts both PML and retinoid signaling function, thus causing the disease [11].”
BackgroundKoushik, A., Wang, M., Anderson, K. E., van den Brandt, P. A., Clendenen, T. V., Eliassen, A. H., Freudenheim, J. L., Genkinger, J. M., Håkansson, N., Marshall, J. R., et al. (2015) · Cancer Causes & Control · doi:10.1007/s10552-015-0626-0 · Cited by 38
“Vitamin A activity is important for the normal control of cellular differentiation and proliferation [2], vitamins C and E have strong antioxidant activity [3], and folate serves as a methyl group donor for DNA synthesis and repair [4]; thus, inadequate levels of these vitamins could enhance carcinogenesis.”
Pasquali, M. A. D. B., Gelain, D. P., Zanotto‐Filho, A., de Souza, L. F., de Oliveira, R. B., Klamt, F., & Moreira, J. C. F. (2008) · Toxicology in Vitro · doi:10.1016/j.tiv.2008.03.007 · Cited by 33
“Both retinol and RA have been suggested as potential therapeutic agents in the treatment of a wide range of diseases, including leukemia, thyroid cancer, and xeroderma pigmentosum (Altucci and Gronemeyer, 2001).”
BackgroundCarotenoid Oxidative/Degradative Products and Their Biological Activities
Wang, X. (2004) · Oxidative stress and disease · doi:10.1201/9780203026649.ch14 · Cited by 36
Retinoic acid receptor modulators: a perspective on recent advances and promises
Álvarez, S., Bourguet, W., Gronemeyer, H., & de Lera, Á. R. (2010) · Expert Opinion on Therapeutic Patents · doi:10.1517/13543776.2011.536531 · Cited by 33
“neuroblastoma, an embryonal tumor of the developing autonomous nervous system [38].”
BackgroundSelf-citationOh, S. W., Moon, S.-H., Park, D. J., Cho, B. Y., Jung, K. C., Lee, D. S., & Chung, J.-K. (2011) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s00259-011-1849-2 · Cited by 33
“In various cancers, especially in haematological malignancies, RA has demonstrable efficacy in combination with conventional chemotherapy regimens [5, 6].”
BackgroundAbdel‐Samad, R., Aouad, P., Gali‐Muhtasib, H. U., Sweidan, Z., Hmadi, R., Kadara, H. N., D’Andrea, E. L., Fucci, A., Pisano, C., & Darwiche, N. (2018) · PubMed Central · Cited by 44
Chemoprevention of photocarcinogenesis by lycopene
Ascenso, A., Ribeiro, H. M., Cabral-Marques, H. M., Oliveira, H., Santos, C., & Simões, S. (2014) · Experimental Dermatology · doi:10.1111/exd.12491 · Cited by 34
Casein Kinase 1α Interacts with Retinoid X Receptor and Interferes with Agonist-induced Apoptosis
Zhao, Y., Qin, S., Atangan, L. I., Molina, Y., Okawa, Y., Arpawong, H. T., Ghosn, C. R., Xiao, J. H., Vuligonda, V., Brown, G., et al. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m404651200 · Cited by 39
YB-1 represses AP1-dependent gene transactivation and interacts with an AP-1 DNA sequence
Samuel, S., Twizere, J., & Bernstein, L. R. (2005) · Biochemical Journal · doi:10.1042/bj20041497 · Cited by 32
Keedwell, R. G., Zhao, Y., Hammond, L., Qin, S., Tsang, K.-Y., Reitmair, A. H., Molina, Y., Okawa, Y., Atangan, L. I., Shurland, D., et al. (2004) · Cancer Research · doi:10.1158/0008-5472.can-03-2763 · Cited by 32
Signalling Pathways Activated by All- trans -Retinoic Acid in Acute Promyelocytic Leukemia Cells
Kambhampati, S., Verma, A., Li, Y., Parmar, S., Sassano, A., & Platanias, L. (2004) · Leukemia & Lymphoma · doi:10.1080/10428190410001722053 · Cited by 29
“ment of new experimental combination treatments with chemotherapy and/or chemopreventive research trials in a variety of human malignancies [6].”
BackgroundInfluentialMedical Management of Persistent and Recurrent Cushing Disease
Fleseriu, M. (2012) · Neurosurgery Clinics of North America · doi:10.1016/j.nec.2012.06.012 · Cited by 34
Involvement of c-Fos in fenretinide-induced apoptosis in human ovarian carcinoma cells
Appierto, V., Villani, M. G., Cavadini, E., Lotan, R., Vinson, C., & Formelli, F. (2003) · Cell Death and Differentiation · doi:10.1038/sj.cdd.4401349 · Cited by 31
Demajo, S., Uribesalgo, I., Gutiérrez, A., Ballaré, C., Capdevila, S., Roth, M., Zuber, J. A., Martín‐Caballero, J., & Croce, L. D. (2013) · Oncogene · doi:10.1038/onc.2013.501 · Cited by 32
Bchini, R., Vasiliou, V., Branlant, G., Talfournier, F., & Rahuel-Clermont, S. (2012) · Chemico-Biological Interactions · doi:10.1016/j.cbi.2012.11.019 · Cited by 33
“RA has been used in the treatment and chemoprevention of certain cancers [7, 8].”
MethodAcyclic retinoid inhibits angiogenesis by suppressing the MAPK pathway
Komi, Y., Sogabe, Y., Ishibashi, N., Sato, Y., Moriwaki, H., Shimokado, K., & Kojima, S. (2009) · Laboratory Investigation · doi:10.1038/labinvest.2009.110 · Cited by 31
“E-mail: skojima@postman.riken.go.jp Laboratory Investigation (2010) 90, 52–60 & 2010 USCAP, Inc All rights reserved 0023-6837/10 $32.00 52 Laboratory Investigation | Volume 90 January 2010 | www.laboratoryinvestigation.org is a synthetic retinoid and activates the RAR and RXR.7 Oral administration of ACR for 12 months…”
BackgroundInfluentialChikamori, K., Hill, J. E., Grabowski, D., Zarkhin, E., Grozav, A. G., Vaziri, S. A. J., Wang, J., Gudkov, A. V., Rybicki, L., Bukowski, R. M., et al. (2006) · Leukemia · doi:10.1038/sj.leu.2404351 · Cited by 34
Tian, D., Zhu, M., Chen, W., Li, J.-S., Wu, R., & Wang, X. (2006) · Food and Chemical Toxicology · doi:10.1016/j.fct.2006.03.013 · Cited by 31
Ageing and cancer as diseases of epigenesis
Gilbert, S. F. (2009) · Journal of Biosciences · doi:10.1007/s12038-009-0077-4 · Cited by 34
“Some cancer cells can actually revert back to being normal cells when put into appropriate environments or when given chemicals that cause them to differentiate (Stewart and Mintz 1981; Altucci and Gronemeyer 2001; Bissell et al. 2002).”
BackgroundNoack, K., Mahendrarajah, N., Hennig, D., Schmidt, L., Grebien, F., Hildebrand, D., Christmann, M., Kaina, B., Sellmer, A., Mahboobi, S., et al. (2016) · Archives of Toxicology · doi:10.1007/s00204-016-1878-5 · Cited by 33
“A new era of treatment began with the introduction of the vitamin A derivative all-trans retinoic acid (ATRA) for the treatment of APL in the 1980s (Altucci and Gronemeyer 2001; Breitman et al. 1981).”
BackgroundMelanoma and nonmelanoma skin cancer chemoprevention: A role for nicotinamide?
Minocha, R., Damian, D. L., & Halliday, G. M. (2017) · Photodermatology Photoimmunology & Photomedicine · doi:10.1111/phpp.12328 · Cited by 32
Liu, X., Shan, W., Li, T., Gao, X., Kong, F., You, H., Kong, D., Qiao, S., & Tang, R. (2021) · BMC Cancer · doi:10.1186/s12885-021-08967-2 · Cited by 35
“In summary, these results indicated that CRBP-1 inhibited Wnt/β-catenin pathway via upregulating WIF1, then suppressed cancer stemness properties in HCC. CRBP-1 activates RARs/RXRs via upregulating intracellular”
BackgroundInfluentialPotential of retinoic acid derivatives for the treatment of corticotroph pituitary adenomas
Labeur, M. S., Páez-Pereda, M., ARZT, E. S., & Stalla, G. K. (2008) · Reviews in Endocrine and Metabolic Disorders · doi:10.1007/s11154-008-9080-6 · Cited by 30
“The activities mediated by the retinoid receptors encompass, for example, the induction of cell-cycle regulators (cyclin-dependent kinase inhibitor p21), the repression of AP1 (the Fos-Jun proto-oncogene product), and the induction of the tumor-cell-selective apoptosis ligand TRAIL [19, 20].”
BackgroundSystems Biophysics of Gene Expression
Vilar, J. M. G., & Saiz, L. (2013) · Biophysical Journal · doi:10.1016/j.bpj.2013.04.032 · Cited by 34
“It exerts its function by binding to DNA as homodimer, homotetramer, or obligatory heterodimerization partner for other nuclear receptors (58).”
BackgroundSilvis, A. M., McCormick, M. L., Spitz, D. R., & Kiningham, K. K. (2015) · Redox Biology · doi:10.1016/j.redox.2015.11.012 · Cited by 31
“but also inhibit cellular proliferation, induce apoptosis [2], and”
BackgroundKim, H., & Lotan, R. (2004) · Cancer Research · doi:10.1158/0008-5472.can-03-2643 · Cited by 31
“First, retinoids may alter gene expression directly through retinoic acid response elements by activating nuclear retinoid receptors that function as ligand-dependent transcription factors (1, 39); second, retinoids may induce or suppress the expression of certain genes indirectly by directly regulating transcription…”
BackgroundCurti, C., Sartori, A. M., Battistini, L., Brindani, N., Rassu, G., Pelosi, G., Lodola, A., Mor, M., Casiraghi, G., & Zanardi, F. (2015) · Chemistry - A European Journal · doi:10.1002/chem.201500083 · Cited by 29
Skvarca, L. B., Han, H. I., Espiritu, E. B., Missinato, M. A., Rochon, E. R., McDaniels, M. D., Bais, A. S., Roman, B. L., Waxman, J. S., Watkins, S. C., et al. (2019) · Disease Models & Mechanisms · doi:10.1242/dmm.037390 · Cited by 38
Kotsopoulos, J., Sukiennicki, G., Muszyńska, M., Gackowski, D., Kąklewski, K., Durda, K., Jaworska, K., Huzarski, T., Gronwald, J., Byrski, T., et al. (2012) · Cancer Causes & Control · doi:10.1007/s10552-012-9975-0 · Cited by 32
“hypothesized to reduce the risk of breast cancer due to its role in the regulation of cell differentiation and apoptosis [47], while carotenoids are important antioxidants [46].”
BackgroundÁlvarez, S., Khanwalkar, H., Álvarez, R., Erb, C., Martínez, C., Rodríguez‐Barrios, F., Germain, P., Gronemeyer, H., & de Lera, Á. R. (2009) · ChemMedChem · doi:10.1002/cmdc.200900214 · Cited by 30
Self-citationClinical efficacy of all-trans retinoic acid for treating adult T cell leukemia
Maeda, Y., Yamaguchi, T., Hijikata, Y., Tanaka, M., Hirase, C., Takai, S., Morita, Y., Sano, T., Miyatake, J., Tatsumi, Y., et al. (2007) · Journal of Cancer Research and Clinical Oncology · doi:10.1007/s00432-007-0334-6 · Cited by 30
“Retinoids inXuence the growth and diVerentiation of normal and malignant cells (Lotan 1980) and have been shown to exert anticarcinogenic and antitumor activities in vitro and in vivo (Smith et al. 1992; Trump 1994; Evans and Kaye 1999; Altucci and Gronemeyer 2001; Guidoboni et al. 2005).”
BackgroundTatebe, H., Shimizu, M., Shirakami, Y., Tsurumi, H., & Moriwaki, H. (2008) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-07-4708 · Cited by 29
Differentiation of Chromaffin Progenitor Cells to Dopaminergic Neurons
Vukićević, V., Schmid, J., Hermann, A., Lange, S., Qin, N., Gebauer, L., Chung, K.-F., Ravens, U., Eisenhofer, G., Storch, A., et al. (2012) · Cell Transplantation · doi:10.3727/096368912x638874 · Cited by 33
Kiss, M., Czimmerer, Z., Nagy, G., Bieniasz-Krzywiec, P., Ehling, M., Pap, A., Póliska, S., Botó, P., Tzerpos, P., Horváth, A., et al. (2017) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1700785114 · Cited by 29
“Administration of selective RXR agonists have a well-established beneficial effect in solid tumors because of their capacity to induce differentiation and/or apoptosis of cancer cells (28).”
Tacke, R., Müller, V., Büttner, M. W., Lippert, W. P., Bertermann, R., Daiss, J. O., Khanwalkar, H., Furst, A., Gaudon, C., & Gronemeyer, H. (2009) · ChemMedChem · doi:10.1002/cmdc.200900257 · Cited by 29
Self-citationRalhan, R., Chakravarti, N., Kaur, J., Sharma, C., Kumar, A., Mathur, M., Bahadur, S., Shukla, N. K., & Deo, S. V. S. (2005) · International Journal of Cancer · doi:10.1002/ijc.21483 · Cited by 29
Delage, B., Bairras, C., Buaud, B., Pallet, V., & Cassand, P. (2005) · International Journal of Cancer · doi:10.1002/ijc.21108 · Cited by 29
Zhang, L., Zhou, Q., Zhang, N., Li, W., Ying, M., Ding, W., Yang, B., & He, Q. (2014) · Cell Cycle · doi:10.4161/cc.28190 · Cited by 29
Barceinas, R. S. Q., García-Regalado, A., Aréchaga-Ocampo, E., Villegas‐Sepúlveda, N., & la Rosa, C. H. G.-D. (2015) · BioMed Research International · doi:10.1155/2015/404368 · Cited by 33
“RAR can form heterodimers with other nuclear receptor types including RXR; this association is needed to enable the protein complexes to bind to retinoic acid responsive elements (RARE) located in the promoters of their target genes and to induce transcription [8].”
Fernandez-Lazaro, C. I., Martínez‐González, M. Á., Aguilera-Buenosvinos, I., Gea, A., Ruiz‐Canela, M., Romanos-Nanclares, A., & Toledo, E. (2021) · Antioxidants · doi:10.3390/antiox10030340 · Cited by 29
Retinoids: novel immunomodulators and tumour‐suppressive agents?
Carratù, M. R., Marasco, C., Mangialardi, G., & Vacca, A. (2012) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2012.02031.x · Cited by 29
“For example, loss of RARb expression is involved in the pathogenesis of several haematological malignancies, as well as in progression of solid tumours such as breast and lung (Altucci and Gronemeyer, 2001; Freemantle et al., 2006).”
BackgroundSalazar, M. D., Ratnam, M., Patki, M., Kisovic, I., Trumbly, R. J., Iman, M., & Ratnam, M. (2011) · Breast Cancer Research · doi:10.1186/bcr2827 · Cited by 28
“In the classical mechanism of the transcriptional activity of class II nuclear receptors, including RAR, the apoprotein is in a repressive association with the target gene and the binding of agonist to the receptor results in gene activation due to a co-regulator switch [38].”
BackgroundRetinoid Receptors in Gastric Cancer: Expression and Influence on Prognosis
Hu, K., Chen, F., Ge, J., Cao, L., & Li, H. (2012) · Asian Pacific Journal of Cancer Prevention · doi:10.7314/apjcp.2012.13.5.1809 · Cited by 28
“The receptors act mainly as RAR–RXR heterodimers, bind to specific DNA sequences (retinoic acid response elements) and act as ligand-dependent transcription factors (Altucci and Gronemeyer, 2001).”
BackgroundRetinoid Agonist Isotretinoin Ameliorates Obstructive Renal Injury
Schaier, M., Jocks, T., Gröne, H., Ritz, E., & Wagner, J. (2003) · The Journal of Urology · doi:10.1097/01.ju.0000084620.64255.b3 · Cited by 28
Santos, M. D. L., Zambrano, A., Sánchez‐Pacheco, A., & Aranda, A. (2007) · Molecular Endocrinology · doi:10.1210/me.2007-0151 · Cited by 33
Retinoids and Alcohol-Related Carcinogenesis
Wang, X. (2003) · Journal of Nutrition · doi:10.1093/jn/133.1.287s · Cited by 28
Hansen, N., Wylie, R. C., Phipps, S. M. O., Love, W. K., Andrews, L., & Tollefsbol, T. O. (2007) · International Journal of Oncology · doi:10.3892/ijo.30.3.641 · Cited by 29
“Retinoids are morphogens that induce the establishment of embryonic patterning, loss of proliferation, cellular differentiation, and apoptosis (40,41) and allow for the selective targeting of highly proliferative cell populations.”
BackgroundMøllersen, L. (2003) · Carcinogenesis · doi:10.1093/carcin/bgg176 · Cited by 28
Shao, X., Liu, Y., Li, Y., Xian, M., Zhou, Q., Yang, B., Ying, M., & He, Q. (2016) · Scientific Reports · doi:10.1038/srep24589 · Cited by 27
“1a) was successfully employed for the treatment of acute promyelocytic leukemias (APLs), which are a distinct subtype of acute myeloid leukemia (AML), it has opened new perspectives for differentiation therapy 1,2 .”
Genista sessilifolia DC . extracts induce apoptosis across a range of cancer cell lines
Bontempo, P., Rigano, D., Doto, A., Formisano, C., Conte, M., Nebbioso, A., Carafa, V., Caserta, G., Sica, V., Molinari, A. M., et al. (2013) · Cell Proliferation · doi:10.1111/cpr.12022 · Cited by 29
Self-citationShimizu, M., Suzui, M., Deguchi, A., Lim, J. T. E., Xiao, D., Hayes, J. H., Papadopoulos, K. P., & Weinstein, I. B. (2004) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-04-0659 · Cited by 27
“The acetylation of histone H4 by histone acetyltransferases results in nucleosomal repulsion, chromatin decondensation, and enhanced transcription (5).”
BackgroundInfluentialHuang, Y., Yang, M., Hu, H., Zhao, X., Bao, L., Huang, D., Song, L., & Li, Y. (2016) · Oncotarget · doi:10.18632/oncotarget.9167 · Cited by 27
“The combination of IFN-β and all-trans retinoic acid (RA) has been shown to synergistically inhibit tumor activity in a number of animal models and in clinical studies [18-19].”
BackgroundArima, K., Ohmuraya, M., Miyake, K., Koiwa, M., Uchihara, T., Izumi, D., Gao, F., Yonemura, A., Bu, L., Okabe, H., et al. (2018) · Oncogene · doi:10.1038/s41388-018-0510-y · Cited by 31
Yan, Z., Chong, S., Lin, H., Yang, Q., Wang, X., Zhang, W., Zhang, X.-K., Zeng, Z., & Su, Y. (2018) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2018.12.036 · Cited by 27
Novel strategies of Raman imaging for monitoring intracellular retinoid metabolism in cancer cells
Abramczyk, H., Imiela, A., & Surmacki, J. M. (2021) · Journal of Molecular Liquids · doi:10.1016/j.molliq.2021.116033 · Cited by 25
The RIG-I–NRF2 axis regulates the mesenchymal stromal niche for bone marrow transplantation
Lou, Q., Jiang, K., Xu, Q., Yuan, L., Xie, S., Pan, Y., Chen, J., Wu, J., Zhu, J., Jiang, L., et al. (2022) · Blood · doi:10.1182/blood.2021013048 · Cited by 29
PTOV1 antagonizes MED25 in RAR transcriptional activation
Youn, H., Park, U., Kim, E., & Um, S. (2010) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2010.11.100 · Cited by 28
Prevention of KLF4-mediated tumor initiation and malignant transformation by UAB30 rexinoid
Jiang, W. G., Deng, W., Bailey, S. K., Nail, C. D., Frost, A. R., Brouillette, W. J., Muccio, D. D., Grubbs, C. J., Lobo-Ruppert, S. M., & Ruppert, J. M. (2009) · Cancer Biology & Therapy · doi:10.4161/cbt.8.3.7486 · Cited by 26
Keedwell, R. G., Zhao, Y., Hammond, L., Wen, K., Qin, S., Atangan, L. I., Shurland, D.-L., Wallace, D. M. A., Bird, R., Reitmair, A. H., et al. (2004) · British Journal of Cancer · doi:10.1038/sj.bjc.6602024 · Cited by 26
“Screening of synthetic analogues has identified compounds that display significant potential as preventive and therapeutic anticancer agents (reviewed in Altucci and Gronemeyer, 2001; Fontana and Rishi, 2002; Hammond et al, 2002; Ortiz et al, 2002; Sun and Lotan, 2002).”
BackgroundJanardhanan, R., Banik, N. L., & Ray, S. K. (2008) · Cancer Letters · doi:10.1016/j.canlet.2007.11.016 · Cited by 26
“Retinoids are known to influence several biological processes such as growth, development, and differentiation [5,6].”
BackgroundNew molecular targeted therapies in thyroid cancer
Milano, A., Chiofalo, M. G., Basile, M., Salzano de Luna, A., Pezzullo, L., & Caponigro, F. (2006) · Anti-Cancer Drugs · doi:10.1097/01.cad.0000224449.16329.c5 · Cited by 26
Dietze, E. C., Caldwell, L. E., Marcom, K., Collins, S. J., Yee, L., Swisshelm, K. L., Hobbs, K. B., Bean, G. R., & Seewaldt, V. L. (2002) · Microscopy Research and Technique · doi:10.1002/jemt.10174 · Cited by 27
Song, J. H., Kim, J. M., Kim, S. H., Kim, H. J., Lee, J. J., Sung, M. H., Hwang, S. Y., & Kim, T. S. (2003) · Life Sciences · doi:10.1016/s0024-3205(03)00515-0 · Cited by 26
Chrabąszcz, K., Kochan, K., Fedorowicz, A., Jasztal, A., Buczek, E., Leslie, L. S., Bhargava, R., Małek, K., Chłopicki, S., & Marzec, K. M. (2018) · The Analyst · doi:10.1039/c7an01883e · Cited by 26
CAR T-cells to treat brain tumors
Guzman, G., Pellot, K., Reed, M. R., & Rodriguez, A. (2023) · Brain Research Bulletin · doi:10.1016/j.brainresbull.2023.02.014 · Cited by 30
“Specific to its role in antitumor activity, RAs induce growth arrest, differentiation, and apoptosis of tumor cells (Altucci and Gronemeyer, 2001); Epping and”
BackgroundHuang, G., Zhang, W., Ren, H., Shen, X., Chen, Q., & Shen, D. (2015) · Cancer Science · doi:10.1111/cas.12802 · Cited by 27
Steinhoff, M., Beyer, M., Roewert-Huber, J., Lukowsky, A., Assaf, C., & Sterry, W. (2008) · Journal of the American Academy of Dermatology · doi:10.1016/j.jaad.2007.07.012 · Cited by 28
Idres, N., Marill, J., & Chabot, G. G. (2005) · Biochemical Pharmacology · doi:10.1016/j.bcp.2005.02.024 · Cited by 25
Mao, W., Liu, Z., Chen, R., Li, A., & Zhou, J. (2006) · Clinical and Experimental Pharmacology and Physiology · doi:10.1111/j.1440-1681.2006.04446.x · Cited by 25
“animal models of carcinogenesis and are being evaluated in clinical trials for the prevention and treatment of cancers.(34,35) Retinoids are also known to regulate gene expression, leading to inhibition of cellullar proliferation, induction of differentiation and apoptosis in a variety of cancer cells.”
MethodCol, J. D., Mastorci, K., Faè, D. A., Muraro, E., Martorelli, D., Inghirami, G. G., & Dolcetti, R. (2012) · Cancer Research · doi:10.1158/0008-5472.can-11-2505 · Cited by 27
“Introduction Mantle cell lymphoma (MCL) is a distinct CD5þ B-cell non– Hodgkin lymphoma (NHL) characterized by the t(11;14)(q13; q32) translocation that leads to overexpression of cyclin D1 and subsequent cyclin D/Rb pathway deregulation (1, 2).”
BackgroundLiu, T.-A., Jan, Y., Ko, B., Wu, Y., Lu, Y.-J., Liang, S.-M., Liu, C.-C., Chen, S.-C., Wang, J. C. K., Shyue, S., et al. (2015) · Oncotarget · doi:10.18632/oncotarget.5734 · Cited by 25
“RA exhibits profound effects on modulating cell differentiation, maturation and proliferation [46, 47].”
BackgroundNguyen, T. G., Hocker, J. E., Thomas, W. D., Smith, S. A., Norris, M. D., Haber, M., Cheung, B. B., & Marshall, G. M. (2003) · Biochemical and Biophysical Research Communications · doi:10.1016/s0006-291x(03)00177-3 · Cited by 25
Savickienė, J., Treigytė, G., Borutinskaite, V. V., Navakauskienė, R., & Magnusson, K. (2006) · Annals of the New York Academy of Sciences · doi:10.1196/annals.1378.081 · Cited by 27
Expression of MCSP and PRAME in conjunctival melanoma
Westekemper, H., Karimi, S., Süßkind, D., Anastassiou, G., Freistuehler, M., Meller, D., Zeschnigk, M., Steuhl, K. P., Bornfeld, N., Schmid, K. W., et al. (2010) · British Journal of Ophthalmology · doi:10.1136/bjo.2009.167445 · Cited by 28
“This is the basis of the antitumoural activity of RA.36 37 Subsequently, the change to, and increase in, PRAME expression may support tumour progression as the suppression of RAR signalling promotes tumour growth and inhibits differentiation.”
BackgroundZNF423: Transcriptional modulation in development and cancer
Behrmann, L., Puller, A., & Horstmann, M. A. (2014) · Molecular & Cellular Oncology · doi:10.4161/23723548.2014.969655 · Cited by 25
“It is known that RA confers a substantial differentiation potential that is exploited as a treatment strategy for various malignancies including neuroblastoma.(45,46) In neuroblastoma, ZNF423 was shown to co-activate the RAR/ RXR nuclear receptor heterodimer after RA binding.”
BackgroundSun, D., Gao, Z., Liu, H., Yuan, Y., & Qu, X. (2012) · Cancer Letters · doi:10.1016/j.canlet.2012.01.012 · Cited by 27
“Upon binding to ligand, the receptors dissociate from the corepressors and bind to receptor coactivators, which have intrinsic histone acetyltransferase activity and facilitate the recruitment of RNA polymerase II and the basal transcription machinery [5,6].”
BackgroundShimizu, M., Imai, K., Moriwaki, H., Shirakami, Y., & Takai, K. (2012) · Journal of Carcinogenesis · doi:10.4103/1477-3163.100398 · Cited by 25
“Retinoids have been used as potential chemotherapeutic or chemopreventive agents because of their differentiation, antiproliferative, and proapoptotic properties.[29,30] For instance, all-trans-retinoic acid is an effective first-line therapy for the treatment of acute promyelocytic leukemia.”
BackgroundNuclear retinoid receptors and pregnancy: placental transfer, functions, and pharmacological aspects
Comptour, A., Rouzaire, M., Belville, C., Bouvier, D., Gallot, D., Blanchon, L., & Sapin, V. (2016) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-016-2332-9 · Cited by 34
Fang, Y., Zhou, X., Lin, M., Ying, M., Luo, P., Zhu, D., Lou, J.-S., Yang, B., & He, Q. (2010) · Molecular Carcinogenesis · doi:10.1002/mc.20687 · Cited by 24
“All-trans retinoic acid (ATRA), a derivative of vitamin A, has multiple functions in biological processes, such as inhibition of proliferation, induction of differentiation, and regulation of apoptosis [1,2].”
BackgroundClinically potential subclasses of retinoid synergists revealed by gene expression profiling.
Ishida, S., Shigemoto‐Mogami, Y., Kagechika, H., Shudo, K., Ozawa, S., Sawada, J.-I., Ohno, Y., & Inoue, K. (2003) · PubMed · Cited by 24
Ohnuma-Ishikawa, K., Morio, T., Yamada, T., Sugawara, Y., Ono, M., Nagasawa, M., Yasuda, A., Morimoto, C., Ohnuma, K., Dang, N. H., et al. (2007) · Cancer Research · doi:10.1158/0008-5472.can-06-1638 · Cited by 24
“On the other hand, on binding of ligands to RAR, the corepressor interface is destabilized to generate a novel interaction surface for coactivators such as histone acetyltransferases and cAMP-responsive element binding protein–binding proteins or p300, leading to transcription initiation (3).”
BackgroundRetinoid receptors in ovarian cancer: expression and prognosis
Kaiser, P. C., Körner, M., Каппелер, А., & Aebi, S. P. (2005) · Annals of Oncology · doi:10.1093/annonc/mdi265 · Cited by 24
“The physiological functions of retinoids include the control of proliferation, apoptosis and differentiation in normal cells during growth and development [6].”
BackgroundNakagawa, T., Shimizu, M., Shirakami, Y., Tatebe, H., Yasuda, I., Tsurumi, H., & Moriwaki, H. (2008) · Cancer Letters · doi:10.1016/j.canlet.2008.08.004 · Cited by 25
“For instance, ACR, the ligand for RXR [24], suppresses pancreatic cancer cell proliferation via binding to RXR because retinoids mediate their biological effects, including anti-cancer effect, by binding to nuclear, ligand-activated receptors [5,6].”
BackgroundBajpe, P. K., Heynen, G. J. J. E., Mittempergher, L., Grernrum, W., de Rink, I., Nijkamp, W., Beijersbergen, R. L., Bernards, R., & Huang, S. (2013) · Molecular and Cellular Biology · doi:10.1128/mcb.01213-12 · Cited by 23
“Twenty-five percent (2,754) of the genes are upregulated in an RA-dependent manner, 14% (1,518) of the genes are downregulated in an RA-dependent manner, and 61% (6,568) of the genes remain unchanged.”
BackgroundNonmelanoma Skin Cancer Chemoprevention
Prado, R., Francis, S. O., Mason, M. N., Wing, G. J., Gamble, R. G., & Dellavalle, R. P. (2011) · Dermatologic Surgery · doi:10.1111/j.1524-4725.2011.02108.x · Cited by 24
Jimenez-Lara, A. M., Aranda, A., & Gronemeyer, H. (2010) · Molecular Cancer · doi:10.1186/1476-4598-9-15 · Cited by 29
“Retinoids regulate important biological processes, such as embryo development, control and maintenance of organ homeostasis, and at the cellular level growth, differentiation and death [2,3].”
BackgroundSelf-citationYao, P., Chen, L., Dobrzański, T. P., Zhu, B., Kang, B., Müller, R., Gonzalez, F. J., & Peters, J. M. (2016) · Molecular Carcinogenesis · doi:10.1002/mc.22607 · Cited by 27
“All rights reserved of their cognate nuclear receptors (RAR/RXR) is mediated by regulating expression of genes involved in cell differentiation, cell cycle, apoptosis, and DNA damage [40,41].”
BackgroundPfoertner, S., Goelden, U., Hansen, W., Toepfer, T., Geffers, R., Ukena, S. N., von Knobloch, R., Hofmann, R. W., Buer, J., & Schrader, A. J. (2005) · Tumor Biology · doi:10.1159/000089262 · Cited by 25
CBP/p300 induction is required for retinoic acid sensitivity in human mammary cells
Dietze, E. C., Troch, M. M., Bowie, M. L., Yee, L., Bean, G. R., & Seewaldt, V. L. (2003) · Biochemical and Biophysical Research Communications · doi:10.1016/s0006-291x(03)00266-3 · Cited by 24
Arce, J. D.-C., Göckel-Krzikalla, E., & Rösl, F. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m702870200 · Cited by 23
Retinoic Acid Reduces Stem Cell–Like Features in Pancreatic Cancer Cells
Herreros‐Villanueva, M., Er, T., & Bujanda, L. (2015) · Pancreas · doi:10.1097/mpa.0000000000000373 · Cited by 23
“In fact, retinoids have been already approved in the clinic for the treatment of several tumors with excellent results in promyelocytic leukemia.(20) In this study, we uncovered the important role of RA in PCSC properties, inducing cell cycle arrest and depleting PCSC”
BackgroundRetinoic acid and arsenic trioxide cooperate for apoptosis through phosphorylated RXR alpha
Tarrade, A., Bastien, J., Bruck, N., Bauer, A., Gianni, M., & Rochette-Egly, C. (2005) · Oncogene · doi:10.1038/sj.onc.1208402 · Cited by 23
“As a consequence, RA induces cell differentiation and growth arrest (Altucci and Gronemeyer, 2001a, b).”
BackgroundZhan, H. C., Gudas, L. J., Bok, D., Rando, R. R., Nanus, D. M., & Tickoo, S. K. (2003) · PubMed · Cited by 23
Brücher, J.-J., Franke, I., Ulrich, J., Gollnick, H. P. M., & Leverkus, M. (2007) · British Journal of Dermatology · doi:10.1111/j.1365-2133.2007.08121.x · Cited by 22
Öztürk, S., Öztürk, T., Uçak, H., Erden, İ., Demir, B., Kayalı, A., & Çiçek, D. (2014) · Cutaneous and Ocular Toxicology · doi:10.3109/15569527.2014.888079 · Cited by 23
Metadata
- Authors
- Altucci, L., & Gronemeyer, H.
- Affiliations
- Centre National de la Recherche Scientifique (FR)
- Venue
- Nature Reviews Cancer
- Published
- 2001-12
- Volume
- 1
- Issue
- 3
- Pages
- 181-193
- ISSN
- 1474-175X (ISSN-L)
- 1474-1768
- OpenAlex
- W1964224609
- Cited by
- 773
- References
- 147
- Citations by year
- 2026: 13 · 2025: 12 · 2024: 16 · 2023: 18 · 2022: 12 · 2021: 16 · 2020: 20 · 2019: 19 · 2018: 20 · 2017: 28 · 2016: 25 · 2015: 36 · 2014: 25 · 2013: 32 · 2012: 47
- FWCI
- 2.91
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- www.springer.com/tdm (vor)
- Locations
- Nature reviews. Cancer (publishedVersion)
- PubMed (publishedVersion)
- HAL (submittedVersion)
- Archivio Istituzionale della Ricerca - Università degli Studi della Campania "Luigi Vanvitelli" (submittedVersion)
- Funders
- Bristol-Myers Squibb
- Institut National de la Santé et de la Recherche Médicale
- Centre National de la Recherche Scientifique
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Retinoids in leukemia and cellular processes
- Health Sciences › Medicine › Oncology › Cancer-related Molecular Pathways
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Peroxisome Proliferator-Activated Receptors
- Keywords
- retinoids, cancer therapy, cancer prevention, tumor suppression, antiproliferative mechanism, teratogenicity, cell proliferation
- MeSH terms
- Antineoplastic Agents, Cell Differentiation, Forecasting, Humans, Models, Biological, Morphogenesis, Neoplasm Proteins, Neoplasms, Retinoids, Skin Neoplasms, Structure-Activity Relationship, Vitamin A, Leukemia, Promyelocytic, Acute, Oncogene Proteins, Fusion, Transcriptional Activation, Gene Expression Regulation, Neoplastic, Anticarcinogenic Agents, Apoptosis, Receptors, Retinoic Acid, Transcription Factor AP-1, Dimerization, Receptor Cross-Talk
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.